- Home
- INTG vs IMA Comparison
INTG vs IMA Comparison
Compare INTG & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INTG | IMA |
|---|---|---|
| Founded | 1965 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building operators | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.2M | 66.3M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | INTG | IMA |
|---|---|---|
| Price | $37.54 | $5.00 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | ★ 92.6K | 11.3K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.67 | N/A |
| Revenue | ★ $74,753,000.00 | $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $56.33 | ★ N/A |
| Revenue Growth | ★ 4.43 | N/A |
| 52 Week Low | $16.88 | $3.94 |
| 52 Week High | $52.00 | $9.10 |
Technical Indicators
Market Signals| Indicator | INTG | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 58.20 | 40.04 |
| Support Level | $31.46 | $4.73 |
| Resistance Level | $38.38 | $6.13 |
| Average True Range (ATR) | 2.24 | 0.27 |
| MACD | 0.43 | -0.01 |
| Stochastic Oscillator | 70.39 | 35.53 |
Price Performance
Historical ComparisonAbout INTG Intergroup Corporation (The)
The Intergroup Corp is a company operating in the real estate sector. It was formed to buy, develop, operate, rehabilitate, and dispose of real property of various types and descriptions, as well as to engage in other related business and investment activities. The company operates through three segments: Hotel, Real Estate, and Investment Transactions. The Hotel Operations segment, which generates the majority of the revenue, covers the operation of the Hilton hotel and garage. The Real Estate Operations segment involves the management of multifamily rental properties, while the Investment Transactions segment includes investments of cash in marketable securities and other assets.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.